We use cookies to ensure that our site works correctly and provides you with the best experience. If you continue using our site without changing your browser settings, we'll assume that you agree to our use of cookies. Find out more about the cookies we use and how to manage them by reading our cookies policy. Hide

Current Issue

29th April 2020
Selected Chemistry & Industry magazine issue

Select an Issue


C&I e-books

C&I e-books

C&I apps

iOS App
Android App


Movers & shakers


US biotechnology company Altavant Sciences, which focuses on drug development for rare respiratory diseases, has appointed Howard M. Lazarus as CMO. Lazarus has over 20 years’ experience in drug development for pulmonary, vascular and interstitial diseases.

Read more
C&I Click to view our flipbook